Works by Lonial, Sagar

Results: 215
    1

    Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE‐MM2 trial.

    Published in:
    EJHaem, 2023, v. 4, n. 4, p. 995, doi. 10.1002/jha2.759
    By:
    • Richardson, Paul G.;
    • Facon, Thierry;
    • Venner, Christopher P.;
    • Bahlis, Nizar J.;
    • Offner, Fritz;
    • White, Darrell;
    • Karlin, Lionel;
    • Benboubker, Lotfi;
    • Voog, Eric;
    • Yoon, Sung‐Soo;
    • Suzuki, Kenshi;
    • Shibayama, Hirohiko;
    • Zhang, Xiaoquan;
    • Villarreal, Miguel;
    • Twumasi‐Ankrah, Philip;
    • Labotka, Richard;
    • Rifkin, Robert M.;
    • Lonial, Sagar;
    • Kumar, Shaji K.;
    • Rajkumar, S. Vincent
    Publication type:
    Article
    2

    Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma.

    Published in:
    EJHaem, 2021, v. 2, n. 1, p. 48, doi. 10.1002/jha2.120
    By:
    • Richardson, Paul G.;
    • Jagannath, Sundar;
    • Chari, Ajai;
    • Vogl, Dan T.;
    • Dimopoulos, Meletios A.;
    • Moreau, Philippe;
    • Dingli, David;
    • Wei, Lee‐Jen;
    • Richter, Joshua;
    • Biran, Noa;
    • Siegel, David;
    • Reichmann, William;
    • Li, Lingling;
    • Tang, Shijie;
    • Saint‐Martin, Jean‐Richard;
    • Joshi, Anita;
    • Kauffman, Michael;
    • Shah, Jatin;
    • Shacham, Sharon;
    • Lonial, Sagar
    Publication type:
    Article
    3
    4

    Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.

    Published in:
    European Journal of Haematology, 2011, v. 86, n. 6, p. 484, doi. 10.1111/j.1600-0609.2011.01602.x
    By:
    • Zangari, Maurizio;
    • Aujay, Monette;
    • Fenghuang Zhan;
    • Hetherington, Kristina L.;
    • Berno, Tamara;
    • Vij, Ravi;
    • Jagannath, Sundar;
    • Siegel, David;
    • Stewart, A. Keith;
    • Wang, Luhua;
    • Orlowski, Robert Z.;
    • Belch, Andrew;
    • Jakubowiak, Andrzej;
    • Somlo, George;
    • Trudel, Suzanne;
    • Bahlis, Nizar;
    • Lonial, Sagar;
    • Singhal, Seema;
    • Kukreti, Vishal;
    • Tricot, Guido
    Publication type:
    Article
    5
    6
    7
    8

    Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma.

    Published in:
    2020
    By:
    • Harvey, R. Donald;
    • Carthon, Bradley C.;
    • Lewis, Colleen;
    • Hossain, Mohammad S.;
    • Zhang, Chao;
    • Chen, Zhengjia;
    • Harris, Wayne B.;
    • Alese, Olatunji B.;
    • Shaib, Walid;
    • Bilen, Mehmet A.;
    • Lawson, David H.;
    • Wu, Christina;
    • Steuer, Conor E.;
    • El-Rayes, Bassel F.;
    • Khuri, Fadlo R.;
    • Lonial, Sagar;
    • Waller, Edmund K.;
    • Ramalingam, Suresh S.;
    • Owonikoko, Taofeek K.
    Publication type:
    journal article
    9
    10
    11
    12

    Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 6, p. 575, doi. 10.1002/ajh.24351
    By:
    • Jurczyszyn, Artur;
    • Grzasko, Norbert;
    • Gozzetti, Alessandro;
    • Czepiel, Jacek;
    • Cerase, Alfonso;
    • Hungria, Vania;
    • Crusoe, Edvan;
    • Silva Dias, Ana Luiza Miranda;
    • Vij, Ravi;
    • Fiala, Mark A.;
    • Caers, Jo;
    • Rasche, Leo;
    • Nooka, Ajay K.;
    • Lonial, Sagar;
    • Vesole, David H.;
    • Philip, Sandhya;
    • Gangatharan, Shane;
    • Druzd-Sitek, Agnieszka;
    • Walewski, Jan;
    • Corso, Alessandro
    Publication type:
    Article
    13

    Generation of human long-lived plasma cells by developmentally regulated epigenetic imprinting.

    Published in:
    Life Science Alliance, 2022, v. 5, n. 3, p. 1, doi. 10.26508/lsa.202101285
    By:
    • Joyner, Chester J.;
    • Ley, Ariel M.;
    • Nguyen, Doan C.;
    • Ali, Mohammad;
    • Corrado, Alessia;
    • Tipton, Christopher;
    • Scharer, Christopher D.;
    • Mi, Tian;
    • Woodruff, Matthew C.;
    • Hom, Jennifer;
    • Boss, Jeremy M.;
    • Duan, Meixue;
    • Gibson, Greg;
    • Roberts, Danielle;
    • Andrews, Joel;
    • Lonial, Sagar;
    • Sanz, Inaki;
    • Eun-Hyung Lee, F.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01120-9
    By:
    • Joseph, Nisha S.;
    • Kaufman, Jonathan L.;
    • Gupta, Vilas A.;
    • Hofmeister, Craig C.;
    • Dhodapkar, Madhav V.;
    • Boise, Lawrence H.;
    • DiCamillo, Sara M.;
    • Roberts, Danielle;
    • Nooka, Ajay K.;
    • Lonial, Sagar
    Publication type:
    Article
    21
    22
    23
    24
    25

    A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00768-5
    By:
    • Chng, Wee-Joo;
    • Lonial, Sagar;
    • Morgan, Gareth J.;
    • Iida, Shinsuke;
    • Moreau, Philippe;
    • Kumar, Shaji K.;
    • Twumasi-Ankrah, Philip;
    • Villarreal, Miguel;
    • Dash, Ajeeta B.;
    • Vorog, Alexander;
    • Zhang, Xiaoquan;
    • Suryanarayan, Kaveri;
    • Labotka, Richard;
    • Dimopoulos, Meletios A.;
    • Rajkumar, S. Vincent
    Publication type:
    Article
    26
    27

    Venetoclax ex vivo functional profiling predicts improved progression-free survival.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00710-9
    By:
    • Gupta, Vikas A.;
    • Matulis, Shannon M.;
    • Barwick, Benjamin G.;
    • Bog, R. Devin;
    • Shebelut, Conrad W.;
    • Shanmugam, Mala;
    • Neri, Paola;
    • Bahlis, Nizar J.;
    • Dhodapkar, Madhav V.;
    • Heffner, Leonard T.;
    • Hofmeister, Craig C.;
    • Joseph, Nisha S.;
    • Lonial, Sagar;
    • Kaufman, Jonathan L.;
    • Jaye, David L.;
    • Nooka, Ajay K.;
    • Boise, Lawrence H.
    Publication type:
    Article
    28

    Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00494-4
    By:
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Thulasi, Praneetha;
    • Badros, Ashraf Z.;
    • Jeng, Bennie H.;
    • Callander, Natalie S.;
    • Potter, Heather A.;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Popat, Rakesh;
    • Degli Esposti, Simona;
    • Byrne, Julie;
    • Opalinska, Joanna;
    • Baron, January;
    • Piontek, Trisha;
    • Gupta, Ira;
    • Dana, Reza;
    • Farooq, Asim V.;
    • Colby, Kathryn;
    • Jakubowiak, Andrzej
    Publication type:
    Article
    29
    30

    Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 10, p. 1, doi. 10.1038/s41408-020-00369-0
    By:
    • Richardson, Paul G.;
    • Lee, Hans C.;
    • Abdallah, Al-Ola;
    • Cohen, Adam D.;
    • Kapoor, Prashant;
    • Voorhees, Peter M.;
    • Hoos, Axel;
    • Wang, Karrie;
    • Baron, January;
    • Piontek, Trisha;
    • Byrne, Julie;
    • Richmond, Scott;
    • Jewell, Roxanne C.;
    • Opalinska, Joanna;
    • Gupta, Ira;
    • Lonial, Sagar
    Publication type:
    Article
    31

    Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41408-020-00357-4
    By:
    • Dimopoulos, Meletios A.;
    • Lonial, Sagar;
    • White, Darrell;
    • Moreau, Philippe;
    • Weisel, Katja;
    • San-Miguel, Jesus;
    • Shpilberg, Ofer;
    • Grosicki, Sebastian;
    • Špička, Ivan;
    • Walter-Croneck, Adam;
    • Magen, Hila;
    • Mateos, Maria-Victoria;
    • Belch, Andrew;
    • Reece, Donna;
    • Beksac, Meral;
    • Spencer, Andrew;
    • Oakervee, Heather;
    • Orlowski, Robert Z.;
    • Taniwaki, Masafumi;
    • Röllig, Christoph
    Publication type:
    Article
    32

    Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents.

    Published in:
    2020
    By:
    • Mina, Roberto;
    • Joseph, Nisha S.;
    • Gay, Francesca;
    • Kastritis, Efstathios;
    • Petrucci, Maria Teresa;
    • Kaufman, Jonathan L.;
    • Montefusco, Vittorio;
    • Gavriatopoulou, Maria;
    • Patriarca, Francesca;
    • Omedé, Paola;
    • Boise, Lawrence H.;
    • Roussou, Maria;
    • Giuliani, Nicola;
    • Oliva, Stefania;
    • Offidani, Massimo;
    • Belotti, Angelo;
    • Jaye, David L.;
    • De Paoli, Lorenzo;
    • Terpos, Evangelos;
    • Lonial, Sagar
    Publication type:
    Letter
    33

    Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0254-0
    By:
    • Schmidt, Timothy M.;
    • Barwick, Benjamin G.;
    • Joseph, Nisha;
    • Heffner, Leonard T.;
    • Hofmeister, Craig C.;
    • Bernal, Leon;
    • Dhodapkar, Madhav V.;
    • Gupta, Vikas A.;
    • Jaye, David L.;
    • Wu, Jiayi;
    • Goyal, Subir;
    • Chen, Zhengjia;
    • Boise, Lawrence H.;
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Kaufman, Jonathan L.
    Publication type:
    Article
    34
    35
    36
    37

    Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 4, p. 725, doi. 10.3109/10428194.2011.619019
    By:
    • Muringampurath-John, Disni;
    • Flowers, Christopher R.;
    • Toscano, Michael;
    • Zhengjia, Chen;
    • Kaufman, Jonathan L.;
    • Arellano, Martha;
    • Bernal-Mizrachi, Leon;
    • Heffner, Leonard T.;
    • Lechowicz, Mary-Jo;
    • McLemore, Morgan;
    • Winton, Elliott;
    • Jaye, David L.;
    • Lonial, Sagar;
    • Khoury, Hanna Jean
    Publication type:
    Article
    38
    39
    40

    Ixazomib for the treatment of multiple myeloma.

    Published in:
    Expert Opinion on Pharmacotherapy, 2018, v. 19, n. 17, p. 1949, doi. 10.1080/14656566.2018.1528229
    By:
    • Richardson, Paul G.;
    • Zweegman, Sonja;
    • O'Donnell, Elizabeth K.;
    • Laubach, Jacob P.;
    • Raje, Noopur;
    • Voorhees, Peter;
    • Ferrari, Renda H.;
    • Skacel, Tomas;
    • Kumar, Shaji K.;
    • Lonial, Sagar
    Publication type:
    Article
    41
    42
    43
    44

    PB2132: EXCALIBER‐RRMM: A PHASE 3, TWO‐STAGE STUDY OF IBERDOMIDE, DARATUMUMAB, AND DEXAMETHASONE VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000975292.31324.26
    By:
    • Lonial, Sagar;
    • Quach, Hang;
    • Dimopoulos, Meletios A.;
    • Rodríguez‐Otero, Paula;
    • Berdeja, Jesus;
    • Richardson, Paul;
    • Kyada, Margee;
    • Chu, Shuyu;
    • Chen, Min;
    • Abad, Patricia;
    • Morando, Juliane;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    45

    P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE‐EXPANSION PHASE OF THE CC‐92480‐MM‐001 TRIAL.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970376.71405.63
    By:
    • Bahlis, Nizar J;
    • Trudel, Suzanne;
    • Quach, Hang;
    • Popat, Rakesh;
    • Lonial, Sagar;
    • Orlowski, Robert Z;
    • Kim, Kihyun;
    • Mateos, Maria‐Victoria;
    • Pawlyn, Charlotte;
    • Ramasamy, Karthik;
    • Martinez‐Lopez, Joaquín;
    • Casas‐Avilés, Ignacio;
    • Spirli, Alessia;
    • Gong, Jing;
    • Amatangelo, Michael;
    • Katz, Jessica;
    • Maciag, Paulo;
    • Peluso, Teresa;
    • Richardson, Paul
    Publication type:
    Article
    46

    P579: SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF AZD5991 IN RELAPSED/ REFRACTORY HEMATOLOGIC MALIGNANCIES: A PHASE 1 FIRST‐IN‐HUMAN STUDY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969220.98838.e7
    By:
    • Desai, Pinkal;
    • Lonial, Sagar;
    • Cashen, Amanda;
    • Kamdar, Manali;
    • Blachly, James S.;
    • Flinn, Ian W.;
    • O’brien, Susan;
    • Garcia, Jacqueline;
    • Korde, Neha;
    • Moslehi, Javid;
    • Wey, Margaret;
    • Cheung, Patricia;
    • Sharma, Shringi;
    • Olabode, Damilola;
    • Chen, Hong;
    • Ali Syed, Firasath;
    • Liu, Mary;
    • Saeh, Jamal;
    • Tibes, Raoul;
    • Andrade, Marcio
    Publication type:
    Article
    47

    Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 2, p. 383, doi. 10.3109/10428194.2014.921296
    By:
    • Nastoupil, Loretta J.;
    • Shenoy, Pareen J.;
    • Ambinder, Alex;
    • Koff, Jean L.;
    • Nooka, Ajay K.;
    • Waller, Edmund K.;
    • Langston, Amelia;
    • Seward, Miray;
    • Kaufman, Jonathan L.;
    • Bernal-Mizrachi, Leon;
    • King, Nassoma;
    • Lechowicz, Mary Jo;
    • Lonial, Sagar;
    • Sinha, Rajni;
    • Flowers, Christopher R.
    Publication type:
    Article
    48
    49
    50

    Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase.

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 5, p. 608, doi. 10.1111/j.1365-2141.2012.09209.x
    By:
    • Muringampurath-John, Disni;
    • Jaye, David L.;
    • Flowers, Christopher R.;
    • Saxe, Debra;
    • Chen, Zhengjia;
    • Lechowicz, Mary J.;
    • Weisenburger, Dennis D.;
    • Bast, Martin;
    • Arellano, Martha L.;
    • Bernal-Mizrachi, Leon;
    • Heffner, Leonard T.;
    • McLemore, Morgan;
    • Kaufman, Jonathan L.;
    • Winton, Elliott F.;
    • Lonial, Sagar;
    • Armitage, James O.;
    • Khoury, Hanna J.
    Publication type:
    Article